The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(7-hydroxynaphthalen-1-yl)biphenyl-4-sulfonamide ID: ALA2322452
PubChem CID: 71716808
Max Phase: Preclinical
Molecular Formula: C22H17NO3S
Molecular Weight: 375.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(Nc1cccc2ccc(O)cc12)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C22H17NO3S/c24-19-12-9-18-7-4-8-22(21(18)15-19)23-27(25,26)20-13-10-17(11-14-20)16-5-2-1-3-6-16/h1-15,23-24H
Standard InChI Key: RZNLXROGNQIVPL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.5562 -14.5902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3744 -14.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7597 -13.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3244 -13.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5059 -13.1821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1261 -13.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5805 -13.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 -14.5143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8322 -14.4866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2173 -13.7582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7777 -13.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9603 -13.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0378 -13.7299 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.4165 -14.4479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0096 -12.9123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2318 -14.4705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6124 -15.1949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4310 -15.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8664 -14.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7201 -13.2830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6591 -13.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4756 -13.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9055 -13.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5199 -12.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7000 -12.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2739 -13.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3113 -11.6506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 22 1 0
21 16 1 0
13 20 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 21 2 0
25 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.45Molecular Weight (Monoisotopic): 375.0929AlogP: 5.01#Rotatable Bonds: 4Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.54CX Basic pKa: ┄CX LogP: 4.79CX LogD: 4.59Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -0.75
References 1. Greig IR, Coste E, Ralston SH, van 't Hof RJ.. (2013) Development of triarylsulfonamides as novel anti-inflammatory agents., 23 (3): [PMID:23265887 ] [10.1016/j.bmcl.2012.11.067 ] 2. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ.. (2014) Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads., 57 (19): [PMID:25244355 ] [10.1021/jm500863j ]